Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

View source ↗

Summary

A clinical trial is assessing the effects of BIIB141 (omaveloxolone) in people with Friedreich ataxia who took it during pregnancy or breastfeeding and on their…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIIB141 (Omaveloxolone) (Omaveloxolone)

Snippet

Sponsor: Biogen | Conditions: Friedreich Ataxia | Status: RECRUITING